The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle ...

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The ...

“In producing any viral vector, the transfection reagent needs to guarantee both high titre and infectivity, as well as quality, to satisfy the needs of a particular disease indication,” says Deb.

How to design and launch a successful Clinical Trial Manufacturing.

Patient associations are shaping trials, asking hard questions, and demanding realistic timelines for treatment delivery.

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.

Built around one of the most prolific academic viral vector manufacturing teams, ViroCell was created to address the global demand for precisely engineered viral vectors. The team leverages its ...